查找临床试验
已按「食管癌」检索，对应国际通用词 esophageal cancer
共找到 248 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:24，每 5 分钟自动同步The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
China
年龄 18 Years – 75 Years
Sun Yat-sen University
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
United States、Brazil、Chile、China、Czechia 等 12 国
年龄 18 Years – 不限
Merck Sharp & Dohme LLC
Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
China
年龄 18 Years – 75 Years
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
China
年龄 18 Years – 不限
Sanofi
Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC
China
年龄 18 Years – 75 Years
The First Affiliated Hospital of Zhengzhou University
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
China
年龄 18 Years – 75 Years
Anhui Provincial Hospital
A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
China
年龄 18 Years – 75 Years
Nanfang Hospital, Southern Medical University
Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma
China
年龄 75 Years – 不限
The First Affiliated Hospital with Nanjing Medical University
Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy
China
年龄 18 Years – 75 Years
Xijing Hospital
A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After First-Line Chemoimmunotherapy in Advanced ESCC (Esophageal Squamous Cell Carcinoma)
China
年龄 18 Years – 75 Years
Sun Yat-sen University
Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer
China
年龄 18 Years – 75 Years
The First Affiliated Hospital of Zhengzhou University
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
United States、China、Germany、Japan、Netherlands
年龄 18 Years – 不限
Eli Lilly and Company